RAFFA WEALTH MANAGEMENT, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1631073
WASHINGTON, DC
Position in PTGX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$7,354
+$1,030 QoQ
Shares Held
60
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#51
of 69 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RAFFA WEALTH MANAGEMENT, LLC holds $112,928 across 35 Biotechnology names. PTGX ranks #4 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
66 | $32,784 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25 | $15,588 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
46 | $8,614 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
This page
|
60 | $7,354 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
191 | $6,759 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
21 | $6,321 | |
| 7 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 8 | MRNA |
Moderna, Inc.
|
63 | $4,411 |
All Filings in PTGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,354 | 60 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $6,324 | 60 | Shares | Sole | 2026-07-27 | |
| 2025-12-31 | $5,240 | 60 | Shares | Sole | 2026-07-27 | |
| 2025-09-30 | $3,985 | 60 | Shares | Sole | 2026-07-27 | |
| 2025-06-30 | $3,316 | 60 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||